Cerebrolysin Use in Patients with Liver Damage—A Translational Study
The treatment of acute life-threatening events in patients suffering from chronic pathologies is problematic, as physicians need to consider multisystemic drug effects. Regarding Cerebrolysin, a Sonic Hedgehog signaling pathway amplifier and one of the few approved neurotrophic treatments for stroke...
Main Authors: | Shandiz Morega, Andrei Gresita, Smaranda Ioana Mitran, Madalina Iuliana Musat, Ianis Kevyn Stefan Boboc, Victor Gheorman, Ion Udristoiu, Carmen Valeria Albu, Costin Teodor Streba, Bogdan Catalin, Ion Rogoveanu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/11/1791 |
Similar Items
-
The impact of stress on the behavior of C57BL/6 mice with liver injury: a comparative study
by: Mădălina Iuliana Mușat, et al.
Published: (2024-03-01) -
Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
by: Konrad Jarosz, et al.
Published: (2023-03-01) -
Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
by: Stefan Strilciuc, et al.
Published: (2023-05-01) -
Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
by: Shandiz Morega, et al.
Published: (2021-12-01) -
Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
by: Nataliia Chemer, et al.
Published: (2019-02-01)